Skip to main content

Table 5 Postoperative characteristics of patients in Group A, C and B [M (Q1, Q3)/n (%)]

From: A randomised controlled trial on roles of prostaglandin E1 nebulization among patients undergoing one lung ventilation

Characteristics

All (n = 90)

A group (n = 30)

B group (n = 30)

C group (n = 30)

P

Score for lung infection

2.53 (1.6, 4.5)

4.0 (3.0, 4.7)

1.0 (1.0, 2.7)*

2.0 (1.0, 3.0)*

< 0.001

Complication

 Pleural effusion

2 (2.22)

0 (0.00)

2 (6.67)

0 (0.00)

0.326

 Pneumothorax

1 (1.11)

0 (0.00)

0 (0.00)

1 (3.33)

1.000

 Anastomotic leakage

3 (3.33)

0 (0.00)

2 (6.67)

1 (3.33)

0.770

 Incision infection

1 (1.11)

0 (0.00)

0 (0.00)

1 (3.33)

1.000

 LOS in hospital, day

21.5 (19.0, 25.7)

21.0 (18.3, 21.0)

21.0 (19.0, 24.7)

22.0 (19.0, 25.7)

0.175

 LOS in ICU, day

1.0 (1.0, 1.0)

1.0 (1.0, 1.0)

1.0 (1.0, 1.0)

1.0 (1.0, 1.0)

0.372

Grade of wound healing

0.318

 1

86 (95.56)

30 (100.00)

29 (96.67)

27 (90.00)

 

 ≥ 2

4 (4.44)

0 (0.00)

1 (3.33)

3 (10.00)

 
  1. *P < 0.05 compared with Group A
  2. LOS, Length of stay
  3. A, 60% FiO2 + 0.1 µg/kg PGE1; B, 40% FiO2 + 0.1 µg/kg PGE1; C, 40% FiO2 + 0.2 µg/kg PGE1